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Studies of interferon (IFN)-treated virus-infected animal cells have revealed the 2-5A system (2-5A synthetase/RNase L
enzymes) as being responsible for virus inhibition only in the case of picornaviridae. To investigate whether those IFN-
induced enzymes could be responsible for inhibition of poxvirus replication, we have generated recombinant vaccinia viruses
(VV) containing the corresponding genes (VV-2-5AS and VV-RL, respectively). RNase L produced in cells infected with VV-
RL leads to rRNA degradation and inhibition of virus protein synthesis, which correlates with about 92% reduction in virus
yields by 48 hr after infection. Combined expression of this enzyme with 2-5A-synthetase further inhibits virus yields. The
pattern of rRNA fragments produced by infection with viruses VV-RL and/or VV-2-5AS is the characteristic for activation
of the 2-5A pathway by IFN treatment. Combined infection of VV-RL together with vesicular stomatitis virus (VSV) demon-
strates this inhibition to be specific for VV and not due to a general effect. Breakdown of rRNA is largely due to the
recombinant vector-derived enzyme, since a C-terminal deletion mutant of RNase L is inactive and the extent of rRNA
degradation induced by infection with VV-RL is similar in cells treated or not with IFN. Moreover, the anti-VV effects of
RNase L is also observed in a cell line lacking the endogenous ds RNA-dependent protein kinase (PKR). Thus, our findings
provide direct evidence for antiviral activity of the 2-5A system on poxviruses. q 1997 Academic Press
Interferons (IFN) are cytokines released from animal presence of ATP, synthesize a complex mixture (referred
to as 2-5A) of 5*-triphosphorylated oligoadenylic acid,cells in response to virus infection or to a variety of other
stimuli. By binding to specific cell surface receptors, IFN ppp(A2*p5)nA, that binds to and activates endoribo-
nuclease RNase L (2). Activated 2-5A-dependent RNaseexerts a wide range of functions, including inhibition of
virus multiplication (1, 2). The varying effects of IFN are L cleaves viral and cellular RNAs, with the result of gen-
eral inhibition of protein synthesis (2).mediated by more than 30 different proteins which are
induced after IFN treatment of the cells (1–3) and only Characterization of the biological role of the 2-5A sys-
the role of a few of them in the antiviral state is beginning tem has advanced by cloning of murine and human
to be elucidated. The best characterized IFN-induced RNase L genes (6) which encode proteins of very inter-
proteins are the Mx family of proteins, the two double- esting molecular architecture (7, 8). Human RNase L
stranded (ds) RNA-dependent enzymes, a 68-kDa protein (83.5 kDa) contains nine ankyrin-like repeats at the N
kinase (PKR) and 2-5A-synthetase, and the 2-5A-depen- terminus which are immediately followed by a complete
dent RNase (RNase L) (3, 4). The proteins 2-5A-synthe- protein kinase domain and next to it, in the C terminus,
tase and RNase L constitute, together with 2-5A-phos- the residues where the endoribonuclease activity is lo-
phodiesterase, what is known as 2-5A pathway or 2-5A cated. Ankyrin repeats have been involved in mediating
system, an IFN-regulated RNA degradative pathway (5). intra- and intermolecular protein–protein interactions in
Although basal levels of these proteins are found in many different types of proteins (9). Systematic biochemi-
most, if not all, mammalian cells, treatment with IFN in- cal studies of IFN-treated virus-infected cells has only
duces at least four different forms of 2-5A-synthetase revealed the 2-5A system as responsible for virus inhibi-
and a unique RNase L (reviewed in Ref. 3). Double- tion in the case of picornaviridae. Direct evidence for
stranded RNA activates the 2-5A-synthetases that, in the antiviral activity of this pathway was shown by constitu-
tive expression of a cDNA encoding human 40-kDa 2-
5A-synthetase (10–12). The inhibitory effect is selective
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been demonstrated in a stable cell line expressing high by cloning of a PstI / KpnI fragment of pPR35-RL into
pRSET-B digested in the same way. It contains the cod-levels of a truncated RNase L which is a dominant nega-
tive mutant of this enzyme (7). However, the contribution ing sequence for RNase L, lacking only nucleotides cod-
ing for the 21 amino acids at the N terminus, fused toof the 2-5A system to the antiviral activities of IFN almost
certainly goes beyond the picornaviridae family of viruses a sequence for 38 new amino acids that includes a
stretch of 6 histidine residues and the 11 amino acidand is obscured by virus-induced IFN-resistance mecha-
nisms (reviewed in Refs. 2 and 3). There is evidence gene 10 leader peptide. We also generated plasmid
pRSET-DN by NcoI digestion of pRSET-RL and religa-suggesting that this is probably the case for vaccinia
virus (VV), a poxvirus which replicates in the cytoplasm tion. This plasmid is similar to pRSET-RL but lacking
sequences coding for amino acids 228 to 741 of RNaseof a wide range of cells, and that has been found to be
resistant to IFN in many cultured cell lines (13, 14), while L. Insertion plasmids pTM-RL and pTM-DN were then
obtained by cloning DNA fragments from plasmidssensitive in others (15) and in experimental animals (16).
The reason for the differential sensitivity of VV to IFN in pRSET-RL (NdeI) and pRSET-DN (NdeI / NcoI), respec-
tively, into the SmaI site of V V insertion vector pTM1-Evivo and in vitro might be related to the ability of the virus
to synthesize interfering products. Indeed, VV displays (27) and they contain 8 extra amino acids in the N termi-
nus in front of the initiation codon provided by pRSET-an impressive variety of defensive strategies to evade
the host response to infection, including counteraction B. Recombinant viruses V V-RL and V V-DN were gener-
ated by homologous recombination of plasmids pTM-of IFN by strategies at two different levels (reviewed in
Ref. 17): production of soluble type I and II IFN receptors RL and pTM-DN into thymidine kinase (tk) gene of
wild-type vaccinia virus (WR) and selection in humanwhich blocks IFN action at a very early stage (18, 19)
and modulation of the activity of the IFN-induced pro- TK0 143B cells with 5*-bromodeoxyuridine (25 mg/ml)
basically as described (29). Two rounds of plaque purifi-teins. The product of ORF E3L competitively binds ds
RNA and prevents the activation of the IFN-induced ds cation yielded homogeneous virus preparations con-
taining the desired genes, as confirmed by SouthernRNA-activated PKR (20) and probably also 2-5A-synthe-
tase (21). Down regulation of the activation of PKR is blot DNA hybridization analysis (data not shown). We
also prepared a rabbit polyclonal anti-RNase L serumalso attained by the product of ORF K3L, a protein with
sequence similarity to eukaryotic initiation factor 2a able to recognize proteins produced by these recombi-
nant viruses, using the C-terminus of this protein (amino(eIF2a), that competitively binds PKR and therefore
blocks inactivation by phosphorylation of eIF2a (22). Be- acids 340 to 741) expressed in E. coli as the antigen.
Exponentially growing E. coli BL21 (DE3) cells carryingsides these proteins, there are results suggesting that
VV uses additional mechanisms to evade IFN action. The plasmid pRSET-D2S, generated by SacI digestion of
pRSET-RL and religation, were induced with 1 mM iso-product of ORF A18R, a mediator in virus RNA metabo-
lism (23), and NPH-I, an enzyme involved in virus tran- propyl-b-D-thiogalactopyranoside. The approximately
45-kDa induced protein, containing a polyhistidinescription (24), could be modulating the 2-5A system but
if this happens by a direct or indirect mechanism remains metal-binding domain, was purified by using a nickel-
charged sepharose resin (Invitrogen) in denaturing con-to be determined. Finally, there are also results sug-
gesting V V-induced ATPase and phosphatase activities ditions. Binding was performed in 6 M guanidine hydro-
chloride, 0.1 M Na-phosphate, 0.01 M Tris/HCl, pH 8.0,being involved in viral interference with the 2-5A system
(25, 26). 10 mM imidazole, and elution in 6 M urea, 0.5 M NaCl,
20 mM Na-phosphate, pH 7.8, 0.5 M imidazole. TheIn this investigation we have examined whether the
IFN-induced enzymes 2-5A-synthetase and 2-5A-depen- protein was precipitated with TCA, the pellet thoroughly
washed in acetone and, once dried, suspended in PBSdent RNase L could be responsible for inhibition of V V
replication in situations of virus sensitivity to IFN. To and used as the antigen for injection into New Zealand
white rabbits. Cell extracts obtained from mock-infectedthis aim, we have generated V V recombinants able to
express individually each one of the IFN-induced en- monkey BSC-40 cells or from cells infected for 24 hr
with V V-RL or V V-DN were therefore analyzed by immu-zymes in the 2-5A pathway and analyzed the effect of
their expression in V V replication, using a cell line noblotting using this sera (Fig. 1B). Proteins of sizes
expected for RNase L (lane 5) and C terminus deletedwhere the virus is otherwise mainly resistant to IFN
action. A recombinant virus where expression of RNase RNase L (RNase L-DN) (lane 6) were only obtained by
coinfection with a second recombinant virus that con-L can be regulated was obtained by cloning of the hu-
man gene, contained in plasmid ZC-5 (6), under the tains a T7 polymerase gene under the control of virus
constitutive promoter p7.5 (vTF7-3, herein vT7) (30). Itcontrol of the bacteriophage T7 promoter into V V inser-
tion vector pTM1-E (27) (Fig. 1A). We first generated is noticeable that for RNase L-DN, besides a main band
of the expected molecular weight for the truncated pro-plasmid pPR35-RL by insertion of a HindIII fragment of
ZC-5 into the SmaI site of pPR35 (28). Plasmid pRSET- tein, there are accompanying products of higher and
lower molecular weights. Similar results were obtainedRL for expression in Escherichia coli was then obtained
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FIG. 1. Inducible expression of nearly full-length and truncated RNase L by recombinant vaccinia viruses. (A) Diagram showing the structure of
the transfected genes pTM-RL and pTM-DN. pT7, bacteriophage T7 polymerase promoter; EMC, encephalomyocarditis virus sequences for cap-
independent translation; solid boxes, pRSET-B sequences comprising an ATG, 6 histidine residues, and the gene 10 leader peptide; open circles,
ankyrin-like repeats in 2-5A-dependent RNase L; gray oval, protein kinase homology region; gray rectangle, region required for RNase activity; Ter,
T7 transcriptional terminator. (B) Expression of the recombinant proteins. Monolayers of BSC-40 cells were either mock-infected (lane 1), single-
infected with VV-RL, VV-DN, or vT7 (m.o.i. 4) (lanes 2–4), or double-infected with vT7 / VV-RL (lane 5) or vT7 / VV-DN (lane 6) (m.o.i. 2 each
virus) for 24 hr. Cell extracts (50 mg) were fractionated in SDS–10% polyacrylamide gels, transferred to nitrocellulose, and analyzed by immunoperoxi-
dase staining after reactivity with rabbit polyclonal serum against RNase L.
using T7-tag, a commercial monoclonal antibody di- Total RNA was extracted from mock-infected cells or
from cells infected either with vT7 (m.o.i. 4) or doublyrected against the gene 10 leader peptide in the N termi-
nus (data not shown). These bands might reflect com- infected with vT7 / VV-DN or vT7/ VV-RL (m.o.i. 2 each
virus) for the indicated periods of time (Fig. 2A) and wasplex conformation of RNase L-DN due to intramolecular
interaction of the ankyrin repeats in the protein. Endoge- analyzed by electrophoresis on formaldehyde agarose
gels. Interestingly, in cells doubly infected with vT7 /nous RNase L could not be detected in mock-infected
BCS-40 cells (Fig. 1B, lane 1), probably because our VV-RL for 24 hr, expression of RNase L induces break-
down of RNA as seen by rRNA cleavage (lane 5). Cleav-polyclonal antibodies prepared against the human pro-
tein are not able to recognize monkey RNase L. age of rRNA required the expression of RNase L and
was not observed in cells infected with vT7 (lane 2) andLate during VV infection of cells in culture, concomitant
with synthesis of complementary mRNAs due to symmet- only to a very low extent in cells expressing RNase L-
DN (lane 7). Because recombinant RNase L producedrical transcription of late genes, 2-5A is produced at high
levels (14, 26) and although it is biologically active when in insect cells has been shown to dimerize upon binding
to 2-5A (31), we cannot exclude that RNase L-DN expres-assayed in vitro it is not able to inhibit VV replication in
cultured cells (14). The resistance of VV to the 2-5A sys- sion might cause minimum activation of endogenous
RNase L. Time-course experiments with vT7 / VV-RLtem is probably due to the existence of viral products
that directly or indirectly counteract the activation of en- showed that rRNA cleavage starts at about 14 hr after
infection (lane 4), coincident with the time when RNasedogenous RNase L. The levels of activatable RNase L
and of 2-5A might be critical in the sensitivity/resistance L is first detected by immunoblotting with sera against
RNase L (Fig. 2B). Discrete rRNA fragments characteris-phenomenon of VV to the 2-5A system. To address this
hypothesis, we measured RNA stability in BSC-40 cells tic of activation of the 2-5A/RNase L pathway (32, 33) are
detected up to 24 hr of infection (Fig. 2A, lanes 4 and 5).infected with vT7 and VV-RL at different times of infection.
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FIG. 2. Induced RNase L cleaves rRNA and inhibits virus protein synthesis in BSC-40 cells. (A) Time-course of RNA degradation. Monolayers of
BSC-40 cells were either mock-infected (lane 1), single-infected with vT7 (m.o.i. 4) (lane 2), or double-infected with vT7 / VV-RL (lanes 3–6) or vT7
/ VV-DN (lane 7) (m.o.i. 2 each virus). Control infections proceeded for 24 hr (lanes 2 and 7) or for the indicated times in the case of vT7 / V V-
RL (lanes 3 – 6). Total RNA was purified using Ultraspec-II RNA Resin Purification System (Biotecx), and the amount of RNA corresponding to 3 1
105 cells was fractionated in 1% agarose-formaldehyde gels and stained with ethidium bromide. Abundant RNAs, 28 S and 18 S rRNA, are indicated.
(B) Time-course of RNase L synthesis. Cells were either mock-infected or infected as before. Cell extracts (50 mg) were fractionated in SDS–10%
polyacrylamide gels, transferred to nitrocellulose, and immunoblotted using rabbit polyclonal antiserum against RNase L as described. (C) Time-
course effect of RNase L on de novo protein synthesis. Monolayers were mock-infected or infected with vT7 / VV-RL or vT7 / VV-DN (m.o.i. 5
each virus) for the indicated times. Cells were labeled for 15 min with 35S-labeled methionine / cysteine (100 mCi/ml) and protein extracts (50 mg)
were fractionated in SDS–polyacrylamide gels and autoradiographed. Lane 1 is over-exposed reflecting lack of shut-off in protein synthesis in
mock-infected cells compared to infected cells (lanes 2–9).
Very little rRNA is detected by 48 hr (Fig. 2A, lane 6), direct evidence that degradation of RNA induced
throughout expression of RNase L by a recombinant VVsuggesting further degradation of RNA fragments first
produced by this or other RNases. Clearly, the results of results in inhibition of virus protein synthesis.
We next examined if by increasing the levels of 2-5AFig. 2 demonstrate that RNase L induced from a recombi-
nant VV causes extensive rRNA degradation, in spite of through expression of 2-5A-synthetase in combination
with RNase L, further enhances the inhibition of VV pro-the synthesis of viral interfering products.
Degradation of RNA observed in cells that express tein synthesis and what is the net effect in viral replica-
tion. To this aim we generated VV recombinant VV-2-RNase L might have as a consequence the inhibition of
virus protein synthesis. Thus, we performed a time- 5AS where expression of human 40-kDa 2-5A-synthetase
is driven by the virus constitutive early-late promoter p7.5.course experiment where, due to shut-off of cellular pro-
tein synthesis as a consequence of infection, we mea- The recombinant was obtained by homologous recombi-
nation of plasmid pSC-2-5AS into wild-type virus (WR)sured de novo synthesis of viral proteins (Fig. 2C). Mono-
layers of BSC-40 cells were either mock-infected (lane thymidine kinase (tk) gene basically as described (29).
The DNA was obtained by cloning a 1.2-kb fragment from1) or infected with vT7 / VV-RL (lanes 2–5) or vT7 /
VV-DN (lanes 6–9) using the same multiplicity for the plasmid pTL4-2-5AS (NcoI / XhoI digested and ends
filled with Klenow fragment) into the SmaI site of VVindicated times. Then, cells were pulse-labeled with [35S]-
methionine / cysteine (100 mCi/ml) in methionine and insertion vector pSC 11 (34). It contains the complete
human 40-kDa 2-5A-synthetase coding sequence, lack-cysteine-free media for 15 min. After washing with PBS,
cells were collected in lysis buffer, protein extracts were ing the methionine residue at the N terminus, and the E.
coli b-galactosidase gene (lac Z) under the control offractionated in SDS–polyacrylamide gels, and, once
dried, gels were autoradiographed. Inhibition of virus pro- a late viral promoter (p11). Recombinant viruses were
selected in human TK0 143B cells using X gal and 5*-tein synthesis by RNase L is clearly observed starting at
about 14 hr after infection (compare lanes 3 and 7) when bromodeoxyuridine (25 mg/ml) (29), and two rounds of
plaque purification yielded homogeneous virus prepara-de novo protein synthesis is maximum (compare lanes
6–9). After 24 hr of infection, low protein synthesis activ- tions. Monkey BSC-40 cells were then infected with dif-
ferent combinations of vT7, VV-RL, VV-DN, or VV-2-5ASity is found in control infections (lanes 8 and 9) but inhibi-
tion by RNase L can still be observed (lanes 4 and 5). A using 5 PFU/cell of each virus. All cultures received a
total virus multiplicity of 15 PFU/cell using an auxiliaryvery abundant protein of size expected for RNase L-DN
is produced in cells infected with vT7 / VV-DN, while recombinant virus VV-LUC (35), which as other recombi-
nants used in this work is a tk(0) virus. We have com-levels of full-length RNase L synthesized are probably
very low (compare lanes 7 and 3). These findings provide pared the stability of rRNA at two different times of infec-
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FIG. 3. Expression of 2-5A-synthetase together with RNase L increases effects on RNA stability and protein synthesis. (A) Analysis of RNA
degradation. Monolayers were either mock-infected (lane 1) or infected with indicated combinations of viruses vT7, VV-RL, VV-DN, and VV-2-5AS
(m.o.i. 5 each virus) (lanes 2–8) for 24 hr (upper panel) or 48 hr (lower panel). Total multiplicity was maintained 15 at all times using VV-LUC when
required. Cells were also treated with IBT (15 mM) and infected with wild-type virus (VV) for 24 hr (m.o.i. 15) (lane VV-(IBT)). Total RNA was purified
as before, and the amount of RNA corresponding to 3 1 105 cells was fractionated in 1% agarose-formaldehyde gels and stained with ethidium
bromide. Abundant RNAs, 28 S and 18 S rRNA, are indicated. (B) Synthesis of recombinant proteins. Monolayers were infected for 48 hr as before,
cell extracts (50 mg) were fractionated in SDS–10% polyacrylamide gels, transferred to nitrocellulose, and immunoblotted using rabbit polyclonal
antiserum specific for RNase L (upper panel) or 2-5A-synthetase (lower panel). (C) De novo protein synthesis. Monolayers were infected for 24 hr
as before and labeled with 35S-labeled methionine / cysteine (100 mCi/ml) for 15 min as described. Protein extracts (50 mg) were fractionated and
dried gels were autoradiographed. Lane 1 is over-exposed reflecting lack of shut-off in protein synthesis in mock-infected cells compared to infected
cells (lanes 2–8).
tion (24 and 48 hr), with levels of expression of the recom- synthetase is similar to the one obtained in cells infected
for 24 hr with wild-type virus (m.o.i. 15) in the presencebinant proteins (RNase L and 2-5A-synthetase), de novo
synthesis of virus proteins, and virus yields. As shown, of isatin-b-thiosemicarbazone (IBT) (15 mM) added to the
culture after viral adsorption and maintained for the dura-cleavage of rRNA is observed at 24 hr of infection with
vT7 / VV-RL (Fig. 3A, lane 5), but degradation increases tion of the experiment (23) (Fig. 3A, upper panel, lane
VV-(IBT)). This is an antipoxviral drug which causes aupon addition of VV-2-5AS (compare lanes 7 to 5). Control
experiments using VV-DN instead of VV-RL demonstrate significant increase in the amount of ds RNA synthesized
during VV infection, therefore inducing cleavage of rRNAthat lack of RNA stability is due to expression of nearly
full-length RNase L (compare lanes 6 and 8 to 5 and 7, with a pattern that is the characteristic one for activation
of the 2-5A pathway (36). The levels of recombinant pro-respectively). At 48 hr, in cells infected with vT7 / VV-
RL or vT7 / VV-RL / VV-2-5AS, rRNA degradation prog- teins RNase L and 2-5A-synthetase were analyzed by
using specific rabbit polyclonal sera and the results ob-resses (Fig. 3A, compare lanes 5 and 7 in upper and
lower panels) and for triple infections most rRNA is de- tained at 48 hr of infection are presented in Fig. 3B.
Cleavage of rRNA correlates in all cases with expressiongraded by this time of infection. Interestingly, expression
of 2-5A-synthetase by itself induces some rRNA cleavage of RNase L and/or 2-5A-synthetase (compare lower panel
in Fig. 3A and 3B). Samples presenting the highest levelsat 48 hr after infection (lane 2). This is probably due to
low levels of activation of endogenous RNase L by the of rRNA degradation also show clear signs of protein
synthesis inhibition with amounts of RNase L and 2-5A-high levels of 2-5A oligos produced by 2-5A-synthetase
expressed by the recombinant virus. Activation of endog- synthetase being, respectively, moderate and severely
inhibited. Analysis of de novo virus protein synthesis atenous RNase L might be also the cause of low levels of
rRNA degradation observed in triple infection vT7 / VV- 24 h of infection (Fig. 3C) showed very low levels of
protein synthesis activity in cells infected with vT7 / VV-DN/ VV-2-5AS at 48 hr of infection (lane 8). Noteworthy,
the pattern of rRNA fragments produced by infection with RL that are further reduced by coexpression of 2-5A-
synthetase (compare lanes 5 and 7).recombinant viruses expressing RNase L and/or 2-5A-
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TABLE 1
Viral Yields in Cells Infected with Recombinant Viruses Expressing RNase L and/or 2-5A-Synthetase
24 hr p.i. 48 hr p.i.
Percentage Percentage
PFU/ml inhibition PFU/ml inhibition
VV-RL 2.4 1 106 (0.3) — 2.4 1 107 (0.5) —
VV-2-5AS 9.6 1 105 (1.2) 60.0 5.4 1 106 (1.1) 77.5
vT7 / VV-RL 6.0 1 105 (1.9) 75.0 1.9 1 106 (0.3) 92.1
vT7 / VV-RL / VV-2-5AS 5.7 1 105 (1.9) 76.3 8.1 1 105 (0.3) 96.6
Note. Monolayers of BSC-40 cells grown in 24-well plates were infected with viruses vT7, VV-RL, and VV-2-5AS (m.o.i. 5 each virus). Total multiplicity
was maintained at 15 at all times, using VV-LUC when required. Cells were collected in media at 24 and 48 hr of infection, freeze-thaw three times,
sonicated, and virus yields titrated on BSC-40 cells. The results are mean values of three independent experiments and standard deviations are given
in parenthesis.
The effect of expression of enzymes in the 2-5A path- used in these experiments, we have tried to separate
the contribution of endogenous and recombinant en-way on virus yields is shown in Table 1. Production of
infectious virus at 24 and 48 hr was quantitated by plaque zymes by using stable cell line SVT2/ZB1.4 expressing
a dominant negative mutant of RNase L (7). However,assay and values referred to results obtained for cells
infected with VV-RL in the absence of vT7. Expression infection of these cells with vT7 / VV-RL produced deg-
radation of rRNA similar to control cells SVT2/pSVL. Theof 2-5A-synthetase by itself causes inhibition of virus
replication by 60 and 77.5% at 24 and 48 hr of infection, most likely explanation is that the levels of mutant RNase
L, which has been described as insufficient to counteractrespectively. Expression of RNase L inhibits virus yields
by 75 and 92.1% at 24 and 48 hr of infection, respectively, the anti-EMCV effect of IFN (7), are below the amounts
of RNase L produced by vT7/ VV-RL infection. To furtherwhile combined expression of RNase L and 2-5A-synthe-
tase enhances the inhibition of virus growth to 96.6% at attempt to separate the effects of activation of endoge-
nous cellular RNase L from those effects due to activa-48 hr. Reduction in virus yields due to RNase L expres-
sion is a late event and it is only apparent after 12 hr of tion of the recombinant VV vector derived enzyme, we
compared RNA stability in BSC-40 cells treated for 18 hrinfection (data not shown). The limited reduction in virus
yields observed in these experiments is probably due to with IFN (1000 international units [U] per ml of human
lymphoblastoid IFN-a, 1 1 108 U/mg, Wellcome Res.) andthe kinetics of RNase L activation. Synthesis of this pro-
tein is detected for the first time 14 hr after infection (Fig. then infected with vT7 (m.o.i. 4) or doubly infected with
vT7 / VV-DN or vT7 / VV-RL (m.o.i. 2 each virus) for2A, lane 4) and inhibition of protein synthesis is clearly
observed starting at about the same time (Fig. 2C, lane 24 hr. In these cells VV replication is nearly resistant to
IFN treatment with only a 35% reduction in virus yields3), a relatively late time point in VV infection when virus
at 24 hr and the levels of RNase L are increased by IFNassembly has been mainly completed. Therefore, the one
log reduction observed in our expression system could
be an underestimate of the potency of the 2-5A system
TABLE 2in VV sensitivity to IFN, or it may represent the maximum
Effect of RNase L Expression on VSV Replicationeffects.
In order to establish that inhibition of VV replication is
VSV / vT7 VSV / vT7specific, we have also analyzed the effect of RNase L
VSV VSV / VV / VV-RL / VV-DN
expression in the replication of vesicular stomatitis virus
(VSV), which is very sensitive to IFN treatment, although 6 hr p.i. 5.0 1 105 3.0 1 105 3.0 1 105 4.0 1 105
14 hr p.i. 9.0 1 105 7.0 1 105 1.2 1 106 1.2 1 108it has been previously described as resistant to the 2-
24 hr p.i. 1.1 1 106 8.0 1 105 9.0 1 105 9.0 1 1055A system (12). Monolayers of BSC-40 cells were in-
fected with VSV (m.o.i. 10), alone or in combination with
Note. Monolayers of BSC-40 cells were either mock-infected or in-
either wild-type VV (m.o.i. 10) or recombinant viruses: fected with wild-type VV (m.o.i. 10) or recombinants: vT7 (m.o.i. 5) /
vT7 (m.o.i. 5) / VV-RL (m.o.i. 5) or vT7 (m.o.i. 5) / VV- VV-RL (m.o.i. 5) or vT7 (m.o.i. 5) / VV-DN (m.o.i. 5). After 30 min of
adsorption, VSV (m.o.i. 10) was also added. Following another 30 minDN (m.o.i. 5) and VSV viral yields were established at
the virus inoculum was removed, cells were washed, and mediumdifferent times of infection. Production of active RNase
containing 2% NCS was added. Infections were also performed with
L, demonstrated by protein analysis (data not shown), VSV or vaccinia viruses alone as controls. Cell supernatants were
has no effect on VSV replication as indicated in Table 2. collected at the indicated times of infection and VSV virus yields titrated
on BSC-40 cells for 14 hr. The results are presented in PFU/ml.Because there is endogenous RNase L in the cells
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FIG. 4. Effects produced by RNase L induced by the recombinant vector are not dependent on other IFN-induced enzymes. (A) Analysis of RNA
degradation in IFN-treated cells. Monolayers of BSC-40 cells were treated for 18 hr with 1000 international units [U] per milliliter of human
lymphoblastoid IFN-a (lower panel) or left untreated (upper panel). Cells were either mock-infected (lane 1), single-infected with vT7 (m.o.i. 4) (lane
2), or double-infected with vT7 / VV-RL (lane 3) or vT7 / VV-DN (lane 4) (m.o.i. 2 each virus) for 24 hr. Total RNA was purified as before, and the
amount of RNA corresponding to 3 1 105 cells was fractionated in 1% agarose-formaldehyde gels and stained with ethidium bromide. Abundant
RNAs, 28 S and 18 S rRNA, are indicated. (B) Effect of RNase L on de novo protein synthesis in cells devoid of PKR. Left panel, immunoblot of
protein extracts prepared from 3T3-like cells derived from homozygous PKR knockout mice (Pkr0/0) or wild-type animals (Pkr///) using a rabbit
polyclonal antiserum specific for mouse PKR. Right panels, monolayers of Pkr /// (upper panel) or Pkr0/0 (lower panel) were mock-infected (lane
1) or infected with vT7 / VV-RL (lanes 2–5) or vT7 / VV-DN (lanes 6–9) (m.o.i. 10 each virus) for the indicated times. Cells were labeled as before
and protein extracts (50 mg) were fractionated in SDS–polyacrylamide gels and autoradiographed.
(13, 26). As shown in Fig. 4A, in cells pretreated with IFN, is responsible for inhibition of VV replication and that
endogenous PKR does not contribute significantly to thecleavage of rRNA could not be observed in vT7 or vT7
/ VV-DN infections (lanes 2 and 4). In cells expressing anti-VV effects of RNase L.
The results presented in this investigation provide di-recombinant RNase L, the extent of rRNA degradation
was only slightly increased by IFN treatment (compare rect evidence for an anti-VV role of ds RNA-dependent
2-5A-synthetase and 2-5A-dependent RNase L, key en-lanes 3). Therefore, RNase L induced by the recombinant
virus VV-RL, and not the endogenous enzyme, is respon- zymes in the molecular mechanisms of IFN action. By
increasing the levels of these enzymes, coupled withsible for rRNA cleavage. Because activation of endoge-
nous PKR could also contribute to inhibition of VV replica- their ability to inhibit protein synthesis, we have been
able to overcome the factors that VV uses to evade thetion, we tested the anti-VV effect of recombinant RNase
L in cells lacking PKR. Mouse cell lines derived from IFN action. Activation of the 2-5A-pathway induced by
infection with VV-2-5AS or VV-RL alone most probablyhomozygous PKR knockout mice (Pkr0/0) or wild-type ani-
mals (Pkr///) (37) (Fig. 4B) were infected with VV recom- requires the participation of endogenous enzymes:
RNase L that becomes active upon increased levels ofbinants and the levels of proteins and virus yields were
evaluated. Absence of murine PKR in the cell line derived 2-5A are produced by infection with VV-2-5AS, or 2-5A
synthetase causing accumulation of 2-5A (14, 26) thatfrom Pkr0/0 mice is shown by immunoblot in Fig. 4B.
Pulse-labeling and SDS– PAGE analysis showed that the activate the increased levels of RNase L achieved by VV-
RL. Basal levels of enzymes in the 2-5A system are pres-inhibition of virus protein synthesis by RNase L was com-
parable in cells with or without PKR and was clearly more ent in variable amounts in most if not all mammalian
cells. RNase L is a low abundance protein which is in-pronounced than in cells expressing inactive RNase L
(Fig. 4B). As a consequence of inhibition of protein syn- creased from 2- to 10-fold in some cells after treatment
with IFN (38). On the contrary, the amount of 2-5A-synthe-thesis by RNase L there is at 24 hr of infection a reduction
in virus yields, referred as in Table 1, of 63% for Pkr 0/0 tase usually increases substantially in response to IFN
(10- to 10,000-fold) although the high levels of 2-5A-syn-and 84% for Pkr/// cells. The results of Fig. 4 provide
additional evidence that expression of recombinant thetase produced in cells transfected with the 40-kDa 2-
5A-synthetase human gene are not sufficient by them-RNase L by VV-RL, and not the endogenous enzyme,
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selves to protect against picornaviruses, and minimum each experiment with auxiliary recombinant tk(0) viruses
warranties the same contribution of all these factors.levels of RNase L are also required (39). These data can
be interpreted to mean that the antiviral state in the cell Therefore, effects observed on rRNA breakdown can be
specifically attributed to the vector-derived enzyme andis compatible with amounts of 2-5A-synthetase in a very
broad range while small changes in levels of activated not to quantitative differences in the levels of viral ds
RNA produced.RNase L are really critical. Our results, obtained in cells
infected with the recombinant viruses, provide evidence In conclusion, in this report we provide direct evidence
with animal cells in culture that by increasing the levelsfor this hypothesis and showed that expression of RNase
L by itself causes greater inhibition of VV replication than of enzymes in the 2-5A pathway we generate an antiviral
state in the cell that is effective upon VV replication butexpression of 2-5A-synthetase (Table 1).
The VV cell system described here for expression of does not affect VSV, which has been previously shown
to be insensitive to this pathway. Since replication of VVenzymes in the 2-5A pathway has two main advantages:
first, it makes it possible to increase the levels of these is severely inhibited in IFN-treated animals, the biological
significance of our findings is to point out that in vivo theenzymes in a controlled fashion, and second, virus infec-
tion provides at the same time a very powerful activator 2-5A system is likely to be a mediator of the antipoxvirus
action of IFN and that modulation of the 2-5A pathwayof the system, i.e., dsRNA, a byproduct of virus replica-
tion. We believe that RNase L activation requires first of might have therapeutic value. The unique system de-
scribed here provides the means to search for virus inter-all production of the protein and then synthesis of ds
RNA, the activator of endogenous 2-5A-synthetase that ference factors throughout their interaction with RNase
L. In addition, by expressing mutant or truncated formsproduces 2-5A oligonucleotides at late times of infection
(14, 25, 26). We have previously described that 2-5A lev- of enzymes in the 2-5A system, it should be possible
to define in vivo functional domains in these importantels in untreated BSC-40 cells are 1.4 nM by 8 hr of infec-
tion with VV and increase to 3.0 nM by 24 hr of infection proteins.
(26). Low concentrations of 2-5A (£1 nM) are normally
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